Key Events This Week
15 Jun: Stock opens at Rs.142.35, surging 5.48%
16 Jun: Sharp 8.15% gain to Rs.153.95 on strong volume
17 Jun: Upgrade to Hold rating announced; stock closes at Rs.157.80 (+2.50%)
18 Jun: Technical momentum shift confirmed; price dips to Rs.152.90 (-3.11%)
19 Jun: Week closes at Rs.151.50 (-0.92%) amid cautious trading

Kronox Lab Sciences Ltd Upgraded to Hold on Technical and Financial Improvements
2026-06-18 08:34:25Kronox Lab Sciences Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 17 June 2026. This change reflects a combination of improved technical indicators, solid quarterly financial performance, and a more favourable valuation context despite some lingering concerns over long-term growth. The company’s Mojo Score has risen to 64.0, signalling a cautious but positive outlook for investors.
Read full news article
Kronox Lab Sciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-06-18 08:05:46Kronox Lab Sciences Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors as the stock price edges higher.
Read full news article
Kronox Lab Sciences Ltd is Rated Sell
2026-06-10 10:11:04Kronox Lab Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Kronox Lab Sciences Ltd is Rated Sell
2026-05-26 10:11:14Kronox Lab Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Kronox Lab Sciences Ltd latest results good or bad?
2026-05-22 19:31:08Kronox Lab Sciences Ltd's latest financial results for the quarter ended March 2026 present a mixed picture, characterized by notable operational efficiency but limited revenue growth. The company reported net sales of ₹26.13 crores, reflecting a sequential growth of 3.40% compared to the previous quarter, although this figure remained unchanged year-on-year. The net profit for the quarter was ₹8.00 crores, indicating a significant sequential increase of 21.40%, which underscores improved profitability despite stagnant sales. A key highlight of the quarter was the operating margin, which expanded to 36.43%, marking the highest level in seven quarters. This improvement was driven by effective cost management, particularly in employee expenses, which decreased from ₹2.14 crores in the previous quarter to ₹1.64 crores. The return on equity (ROE) stood at an impressive 28.71%, reflecting the company's ability ...
Read full news article
Kronox Lab Sciences Q4 FY26: Record Profitability Masks Growth Concerns
2026-05-22 09:56:35Kronox Lab Sciences Ltd., a micro-cap speciality chemicals manufacturer with a market capitalisation of ₹515.75 crores, reported its strongest quarterly profit in Q4 FY26 (January-March 2026), yet the stock's muted response reflects growing investor concerns about the company's anaemic revenue growth trajectory. Net profit surged 21.40% quarter-on-quarter to ₹8.00 crores, marking the highest quarterly profit in company history, whilst operating margins expanded sharply to 36.43%. However, revenue remained flat year-on-year at ₹26.13 crores, exposing the fundamental challenge facing this Ahmedabad-based chemical manufacturer.
Read full news article






